Luis H. Camacho

13.9k total citations
104 papers, 3.1k citations indexed

About

Luis H. Camacho is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Luis H. Camacho has authored 104 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 40 papers in Molecular Biology and 22 papers in Immunology. Recurrent topics in Luis H. Camacho's work include Cancer Immunotherapy and Biomarkers (22 papers), CAR-T cell therapy research (16 papers) and Cancer Treatment and Pharmacology (15 papers). Luis H. Camacho is often cited by papers focused on Cancer Immunotherapy and Biomarkers (22 papers), CAR-T cell therapy research (16 papers) and Cancer Treatment and Pharmacology (15 papers). Luis H. Camacho collaborates with scholars based in United States, Spain and Italy. Luis H. Camacho's co-authors include Jesús Gómez-Navarro, Antoni Ribas, C. A. Bulanhagui, Dmitri Pavlov, James M. Reuben, John A. Glaspy, John M. Kirkwood, Viviana Bozón, Charla A. Parker and Gabriel Lopez‐Berestein and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Luis H. Camacho

99 papers receiving 3.0k citations

Peers

Luis H. Camacho
Frank Stenner Switzerland
David Propper United Kingdom
Alessandro Ottaiano Italy
Bernard Drénou France
Clara Natoli Italy
Philippe Bertheau France
Nicolas Larmonier United States
H. Zwierzina Austria
D. Khayat France
Jules E. Harris United States
Frank Stenner Switzerland
Luis H. Camacho
Citations per year, relative to Luis H. Camacho Luis H. Camacho (= 1×) peers Frank Stenner

Countries citing papers authored by Luis H. Camacho

Since Specialization
Citations

This map shows the geographic impact of Luis H. Camacho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis H. Camacho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis H. Camacho more than expected).

Fields of papers citing papers by Luis H. Camacho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis H. Camacho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis H. Camacho. The network helps show where Luis H. Camacho may publish in the future.

Co-authorship network of co-authors of Luis H. Camacho

This figure shows the co-authorship network connecting the top 25 collaborators of Luis H. Camacho. A scholar is included among the top collaborators of Luis H. Camacho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis H. Camacho. Luis H. Camacho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elmorsi, Rami, Luis H. Camacho, David D. Krijgh, et al.. (2024). Optimizing Morbidity in Unplanned Soft Tissue Sarcoma Excisions. Annals of Plastic Surgery. 93(3). 361–368.
2.
Perrault, David, et al.. (2023). T-Line mesh as a safe and effective option for abdominal wall reinforcement with autologous breast reconstruction. Journal of Plastic Reconstructive & Aesthetic Surgery. 84. 273–275. 1 indexed citations
3.
Schwartzberg, Lee S., Francis P. Arena, Edward H. Kaplan, et al.. (2017). A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic Cancer. Journal of Cancer. 8(10). 1872–1883. 39 indexed citations
4.
Eroglu, Zeynep, Dae Won Kim, Xiaoyan Wang, et al.. (2015). Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab. European Journal of Cancer. 51(17). 2689–2697. 64 indexed citations
5.
Mullane, Kathleen M., Drew J. Winston, M. S. Wertheim, et al.. (2013). Safety and Immunogenicity of Heat-Treated Zoster Vaccine (ZVHT) in Immunocompromised Adults. The Journal of Infectious Diseases. 208(9). 1375–1385. 59 indexed citations
6.
Kim, Kevin B., Víctor G. Prieto, Richard W. Joseph, et al.. (2012). A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma. Melanoma Research. 22(4). 294–301. 58 indexed citations
7.
Galsky, Matthew D., Luis H. Camacho, E. Gabriela Chiorean, et al.. (2011). Retrospective Analysis of Satraplatin in Patients with Metastatic Urothelial Cancer Refractory to Standard Platinum-Based Chemotherapy. Clinical Genitourinary Cancer. 9(1). 27–30. 4 indexed citations
8.
Ribas, Antoni, Luis H. Camacho, Sun Min Lee, et al.. (2010). Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma. Journal of Translational Medicine. 8(1). 89–89. 29 indexed citations
9.
Camacho, Luis H., JoAnn Lim, David S. Hong, et al.. (2010). Exploratory Study of Hepatic Arterial Infusion Oxaliplatin With Systemic 5-Fluorouracil/Bevacizumab in Patients With Refractory Solid Tumor and Extensive Liver Metastases. Clinical Colorectal Cancer. 9(5). 311–314. 8 indexed citations
10.
Tsimberidou, Apostolia M., Stacy L. Moulder, Siqing Fu, et al.. (2010). Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement. Cancer Chemotherapy and Pharmacology. 66(6). 1087–1093. 16 indexed citations
11.
Camacho, Luis H., et al.. (2010). Chemokine expression in tumor-to-tumor metastasis. Oncology Letters. 1(3). 449–452. 5 indexed citations
12.
Yoon, Chan Seok, Nicholas E. Papadopoulos, Luis H. Camacho, et al.. (2010). The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanoma. Melanoma Research. 20(1). 43–47. 8 indexed citations
13.
Comı́n-Anduix, Begoña, Jason Jalil, Alain P. Algazi, et al.. (2008). Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma. Journal of Translational Medicine. 6(1). 22–22. 64 indexed citations
14.
Camacho, Luis H., et al.. (2008). XANTHOGRANULOMATOUS PYELONEPHRITIS PRESENTING AS A PSEUDOTUMOR IN A 5 YEAR-OLD BOY. Archives of Disease in Childhood. 93.
15.
Camacho, Luis H., Razelle Kurzrock, Alex Cheung, et al.. (2007). Pilot study of regional, hepatic intra‐arterial paclitaxel in patients with breast carcinoma metastatic to the liver. Cancer. 109(11). 2190–2196. 26 indexed citations
16.
Gómez-Navarro, Jesús, Scott Antonia, Jeffrey A. Sosman, et al.. (2007). Survival of patients (pts) with metastatic melanoma treated with the anti-CTLA4 monoclonal antibody (mAb) CP-675,206 in a phase I/II study. Journal of Clinical Oncology. 25(18_suppl). 8524–8524. 16 indexed citations
17.
18.
Reuben, James M., Bang‐Ning Lee, Changping Li, et al.. (2006). Biologic and immunomodulatory events after CTLA‐4 blockade with ticilimumab in patients with advanced malignant melanoma. Cancer. 106(11). 2437–2444. 104 indexed citations
19.
Camacho, Luis H., Jennifer Bacik, Alexander Cheung, & David R. Spriggs. (2005). Presentation and subsequent publication rates of phase I oncology clinical trials. Cancer. 104(7). 1497–1504. 42 indexed citations
20.
Kim, Kevin B., Ángela Sanguino, Nicholas E. Papadopoulos, et al.. (2004). Biochemotherapy in patients with metastatic anorectal mucosal melanoma. Cancer. 100(7). 1478–1483. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Stenner Breakdown of academic impact, for papers by David Propper Breakdown of academic impact, for papers by Alessandro Ottaiano Breakdown of academic impact, for papers by Bernard Drénou Breakdown of academic impact, for papers by Clara Natoli Breakdown of academic impact, for papers by Philippe Bertheau Breakdown of academic impact, for papers by Nicolas Larmonier Breakdown of academic impact, for papers by H. Zwierzina Breakdown of academic impact, for papers by D. Khayat Breakdown of academic impact, for papers by Jules E. Harris
Rankless by CCL
2026